Twin Tree Management
AGN

Twin Tree Management’s Allergan Inc AGN Stock Holding History

Twin Tree Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,500
Closed -$744K – 1422
2014
Q4 		$744K Sell
3,500
-7,900
-69% -$1.57M 0.02% 684
2014
Q3 		$2.03M Sell
11,400
-32,700
-74% -$5.43M 0.05% 378
2014
Q2 		$7.46M Buy
44,100
+40,400
+1,092% +$6.29M 0.17% 118
2014
Q1 		$459K Sell
3,700
-11,100
-75% -$1.35M 0.01% 765
2013
Q4 		$1.64M Sell
14,800
-13,100
-47% -$1.25M 0.04% 458
2013
Q3 		$2.52M Buy
27,900
+7,000
+33% +$628K 0.09% 262
2013
Q2 		$1.76M Buy
+20,900
New +$2.17M 0.07% 333

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Twin Tree Management's AGN Position: Q3 2014 in Review

Twin Tree Management sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 11,008 shares — an estimated $1.83M sold.

Twin Tree Management first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $2.6M in Q1 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Twin Tree Management reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Twin Tree Management sold 11,008 Allergan Inc shares in Q3 2014, an estimated $1.83M.
  • Twin Tree Management first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Twin Tree Management's Allergan Inc position peaked at $2.6M in Q1 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Twin Tree Management's 13F filing for Q3 2014, filed 14 Nov 2014.